1. Oct-B: A derivative of L-BAIBA significantly alleviating high-fat diet-induced obesity in mice.
- Author
-
Wang J, Wei S, Guo J, Xie X, Sun W, Zhao S, Meng J, Wang F, Wang J, Rong R, and Jiang P
- Subjects
- Animals, Male, Mice, Liver drug effects, Liver metabolism, Liver pathology, Adipose Tissue, White drug effects, Adipose Tissue, White metabolism, Adipose Tissue, White pathology, Lipid Metabolism drug effects, Diet, High-Fat adverse effects, Obesity drug therapy, Obesity metabolism, Obesity pathology, Obesity prevention & control, Obesity etiology, Mice, Inbred C57BL, Aminoisobutyric Acids pharmacology
- Abstract
The rising prevalence of obesity is a global health concern. Supplementation with (S)-β-aminoisobutyric acid (L-BAIBA) has shown potential in preventing obesity and related metabolic disorders induced by high-fat diets. However, developing effective and low-toxicity BAIBA derivatives remains a challenging yet promising field. In this study, we introduce Oct-B, a novel BAIBA ester compound, which exhibits 80-fold greater efficacy than L-BAIBA in alleviating obesity in high-fat diet-fed mice. Our results demonstrate that Oct-B significantly reduces serum TG, TC, LDL-C, and the activities of ALT and AST, and also reduces TG and TC in liver, surpassing the effects of L-BAIBA. Histological analysis shows that Oct-B significantly decreases lipid accumulation in liver tissues, normalizes mast cells in white adipose tissue, and upregulates the expression of UCP1 protein in white adipose tissue. The qRT-PCR results indicated Oct-B alleviates obesity by downregulating lipogenic genes (PPARγ, ACC1, FAS), upregulating lipolysis related genes (PPARα, HSL) and thermogenic gene UCP1. Additionally, quantitative mass spectrometry reveals a marked increase in L-BAIBA levels in white fat, brown fat, serum, and muscle following Oct-B administration. These findings suggest that Oct-B is an efficient L-BAIBA substitute, offering a promising therapeutic approach for preventing and treating high-fat diet-induced obesity., Competing Interests: Declaration of Competing Interest All authors declare they have no actual or potential competing financial interest., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF